Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Robert McWhirter
Kneat.com IncKSI.VBUYFeb 26, 2021
A company that has a software to bring efficiency to the pharmaceutical industry. It helps with work flows. Their strategy is land and expand. Results were better than expected. The sales cycle is long. There is significant upside as they convert to sales and visible recurring revenue. Higher profitability is on the horizon.
Robert McWhirterUnknown
$3.15
Stock price when the opinion was issued
$4.25
As of Nov 12, 2021. Market Open.
Technology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
PAST TOP PICK
(A Top Pick Aug 22/22, Down 17%)
Software company that is based in Ireland.
Offers compliance and validation software in life sciences business.
Currently has 8/10 of top pharma & 18/20 top bio-pharma companies as customers.
Growing customer base at a rapid rate.
Very positive on outlook of business.
Will continue to own shares.
Technology
